skip to Main Content

Outcomes in Pancreatic Cancer Surveillance Program for Carriers of Germline CDKN2A Pathogenic Variants

Newsfeed image, light gray text on dark gray background
In a Dutch study reported in the Journal of Clinical Oncology, Klatte et al provided findings from a 20-year follow-up of a pancreatic cancer surveillance program including carriers of germline CDKN2A pathogenic variants.

The study included 347 carriers in the Netherlands who participated in surveillance for pancreatic ductal adenocarcinoma in a program initiated in the year 2000 at Leiden University Medical Center. Surveillance included annual magnetic resonance imaging with magnetic resonance cholangiopancreatography and optional endoscopic ultrasound. Read more . . . 


Back To Top